Hyperlipidemia Disrupts Cerebrovascular Reflexes and Worsens Ischemic Perfusion Defect

Hyperlipidemia is a highly prevalent risk factor for coronary and cervical atherosclerosis and stroke. However, even in the absence of overt atherosclerosis, hyperlipidemia disrupts endothelial and smooth muscle function. We investigated the impact of hyperlipidemia on resting-brain perfusion, fundamental cerebrovascular reflexes, and dynamic perfusion defect during acute focal ischemia in hyperlipidemic apolipoprotein E knockout mice before the development of flow-limiting atherosclerotic stenoses. Despite elevated blood pressures, absolute resting cerebral blood flow was reduced by 20% in apolipoprotein E knockout compared with wild type when measured by [14C]-iodoamphetamine technique. Noninvasive, high spatiotemporal resolution laser speckle flow imaging revealed that the lower autoregulatory limit was elevated in apolipoprotein E knockout mice (60 vs. 40 mm Hg), and cortical hyperemic responses to hypercapnia and functional activation were attenuated by 30% and 64%, respectively. Distal middle cerebral artery occlusion caused significantly larger perfusion defects and infarct volumes in apolipoprotein E knockout compared with wild type. Cerebrovascular dysfunction showed a direct relationship to the duration of high-fat diet. These data suggest that hyperlipidemia disrupts cerebral blood flow regulation and diminishes collateral perfusion in acute stroke in the absence of hemodynamically significant atherosclerosis.

[1]  C. Wanner,et al.  Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA. , 2003, Journal of the American Society of Nephrology : JASN.

[2]  M. Moskowitz,et al.  Migraine Mutations Increase Stroke Vulnerability by Facilitating Ischemic Depolarizations , 2012, Circulation.

[3]  O. Levin,et al.  [Cerebral amyloid angiopathy]. , 2014, Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova.

[4]  A. Demchuk,et al.  Is cholesterol a risk factor for stroke?: Yes. , 1999, Archives of neurology.

[5]  R. Ross,et al.  ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[6]  D. Heistad,et al.  Atherosclerosis, vascular remodeling, and impairment of endothelium-dependent relaxation in genetically altered hyperlipidemic mice. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[7]  P. Amarenco Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction , 2001, Neurology.

[8]  N. Maeda,et al.  Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[9]  Jeroen van der Grond,et al.  Effect of cerebrovascular risk factors on regional cerebral blood flow. , 2008, Radiology.

[10]  Leslie A. Smith,et al.  Hypercholesterolemia Impairs Endothelium-Dependent Relaxations in Common Carotid Arteries of Apolipoprotein E-Deficient Mice , 2001, Stroke.

[11]  N. Maeda,et al.  Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. , 1992, Science.

[12]  J. LaManna,et al.  Neuroprotection in Diet-Induced Ketotic Rat Brain after Focal Ischemia , 2008, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  M. Moskowitz,et al.  Laser Speckle Flowmetry for the Study of Cerebrovascular Physiology in Normal and Ischemic Mouse Cortex , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[14]  A. Hofman,et al.  Cerebral CO2 reactivity, cholesterol, and high-density lipoprotein cholesterol in the elderly , 2000, Neurology.

[15]  G. Rosadini,et al.  Regional Cerebral Blood Flow in Familial Hypercholesterolemia , 1994, Stroke.

[16]  N. Hattori,et al.  Alterations in Nitric Oxide and Endothelin-1 Bioactivity Underlie Cerebrovascular Dysfunction in ApoE-Deficient Mice , 2010, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[17]  Matthias Orth,et al.  Expression of Human Apolipoprotein E3 or E4 in the Brains ofApoe−/− Mice: Isoform-Specific Effects on Neurodegeneration , 1999, The Journal of Neuroscience.

[18]  P. Black,et al.  L-arginine normalizes endothelial function in cerebral vessels from hypercholesterolemic rabbits. , 1991, The Journal of clinical investigation.

[19]  M. Moskowitz,et al.  Strain-related differences in susceptibility to transient forebrain ischemia in SV-129 and C57black/6 mice. , 1997, Stroke.

[20]  R. Pearlstein,et al.  Apolipoprotein E deficiency worsens outcome from global cerebral ischemia in the mouse. , 1999, Stroke.

[21]  M. Febbraio,et al.  CD36/Fatty Acid Translocase, An Inflammatory Mediator, Is Involved in Hyperlipidemia-Induced Exacerbation in Ischemic Brain Injury , 2008, The Journal of Neuroscience.

[22]  A D Roses,et al.  Increased neuronal damage in apolipoprotein E-deficient mice following global ischaemia. , 1999, Neuroreport.

[23]  R. Chen,et al.  Amlodipine treatment reduces stroke size in apolipoprotein E-deficient mice. , 2006, American journal of hypertension.

[24]  M. Moskowitz,et al.  The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo. , 2007, The Journal of clinical investigation.

[25]  Leslie A. Smith,et al.  Mechanism of Endothelial Dysfunction in Apolipoprotein E-Deficient Mice , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[26]  J. Roberts,et al.  The behavioural effect of middle cerebral artery occlusion on apolipoprotein-E deficient mice , 2002, Behavioural Brain Research.

[27]  G. Hamann,et al.  Increased cerebral CO(2) reactivity after heparin-mediated extracorporal LDL precipitation (HELP) in patients with coronary heart disease and hyperlipidemia. , 1999, Stroke.

[28]  N. Scarpato,et al.  Cerebral Blood Flow Velocity and Systemic Vascular Resistance After Acute Reduction of Low‐Density Lipoprotein in Familial Hypercholesterolemia , 1993, Stroke.

[29]  A. Soricelli,et al.  Relative protection from cerebral atherosclerosis of young patients with homozygous familial hypercholesterolemia. , 1991, Atherosclerosis.

[30]  R. Pearlstein,et al.  Regional CBF in apolipoprotein E‐deficient and wild type mice during focal cerebral ischemia , 1998, Neuroreport.

[31]  Phillip B. Jones,et al.  Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.

[32]  K. Stokes,et al.  Cerebral Microvascular Responses to Hypercholesterolemia: Roles of NADPH Oxidase and P-Selectin , 2004, Circulation research.

[33]  A. Roses,et al.  Apolipoprotein E-Deficient Mice Have Increased Susceptibility To Focal Cerebral Ischemia , 1997, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  D. Heistad,et al.  Cerebral Vascular Dysfunction During Hypercholesterolemia , 2007, Stroke.

[35]  E. Rubin,et al.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells , 1992, Cell.

[36]  M. Moskowitz,et al.  Rho-Kinase Inhibition Acutely Augments Blood Flow in Focal Cerebral Ischemia via Endothelial Mechanisms , 2007, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.